Navigation Links
Savient Pharmaceuticals Names Kenneth J. Zuerblis Chief Financial Officer
Date:9/12/2011

>www.savient.com.

FORWARD-LOOKING STATEMENTSAll statements other than statements of historical facts included in this press release are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trends and uncertainties are in some instances beyond our control. Words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "will" and other similar expressions identify forward-looking statements, although not all forward-looking statements contain these identifying words. In particular, any statements regarding the safety and efficacy of KRYSTEXXA®, status of our KRYSTEXXA marketing efforts and additional plans related thereto, market demand and reimbursement for KRYSTEXXA, our view of the refractory chronic gout (RCG) market size based on the completion of our recent comprehensive study, and our market expansion plans including our MAA filing before the EMA are forward-looking statements. These forward-looking statements involve substantial risks and uncertainties and are based on our assessment and interpretation of the currently available data and information, current expectations, assumptions, estimates and projections about our business and the biopharmaceutical and specialty pharmaceutical industries in which we operate. Important factors that may affect our ability to achieve the matters addressed in these forward-looking statements include, but are not limited to, our ability to commercialize KRYSTEXXA; the risk that the market for KRYSTEXXA is smaller than we have anticipated; our ability to retain the personnel whom we have hired and to hire the remaining personnel necessary to complete the build out of our commercial team; our reliance on third parties to manufacture KRYSTEXXA; competition from existing therapies and therapies that are currently under development, includi
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
2. Savient Pharmaceuticals to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
3. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
4. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
5. Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency
6. Savient Pharmaceuticals Reports First Quarter 2011 Financial Results
7. Savient Pharmaceuticals Submits European Marketing Authorization Application for KRYSTEXXA®
8. Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
9. Savient Pharmaceuticals to Present Multiple Abstracts at The European League Against Rheumatism (EULAR) 2011 Annual Congress
10. Savient Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
11. Savient Pharmaceuticals to Hold First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)...  (MUSE Booth # 1510)What:Automating continuous vital sign ... invaluable in any hospital setting, but particularly for ... and mainstream in healthcare, the integration of data ... gaining traction in MEDITECH facilities.During MUSE 2015 (Medical ... Manager & Clinical Analyst at McLaren Huron Hospital, ...
(Date:5/21/2015)... WASHINGTON , May 21, 2015 ... Century Cures legislation by the House Energy ... (SCPC) thanked the Committee for recognizing the unique ... providers, and for including bill language exempting Part ... settings from a proposed medication management "lock-in" provision. ...
(Date:5/21/2015)... and SEATTLE , May 21, 2015 ... development of robotics, sensors and medical devices, announced today ... company,s Chief Financial Officer and head of Corporate Development ... corporate development, business development and finance roles, including positions ... Pendrell Corporation.  Mr. Woo will be located in Sarcos, ...
Breaking Medicine Technology:Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3SCPC Applauds Unanimous House Panel Passage of 21st Century Cures Bill Recognizing Unique Challenges Facing Long Term Care (LTC) Pharmacy Patients, Providers 2Sarcos Corp. Announces Preston Woo as CFO and Head of Corporate Development 2
(Date:5/21/2015)... The Johns Hopkins Alliance for Science and Technology ... Board has selected a research project at the Veterans ... two $50,000 Abell Foundation Award for Excellence in Innovation ... Developed by the VA Maryland Exercise and Robotics ... Maryland School of Medicine and Massachusetts Institute of Technology ...
(Date:5/21/2015)... May 21, 2015 How do you stop ... question for parents and school administrators, but a Miami Lice ... based in southern Florida, is devising new ways to ... professionals will tell you, the first step is education and ... classrooms, head lice and how they spread are still widely ...
(Date:5/21/2015)... May 21, 2015 The ThedaCare Center for ... new full-time role as president. Barnas is based in Appleton ... focus is to coach, lead and support Center teams that ... , Transforming the patient experience , Making ... across North America. , The Center is excited ...
(Date:5/21/2015)... 21, 2015 PharmApprove – ... the pharmaceutical and biotechnology industries – will be presenting ... BIO International Convention in Philadelphia, PA. PharmApprove’s session, titled ... Payer,” will take place on June 16th at ... PharmApprove President and CSO, will moderate the group, which ...
(Date:5/21/2015)... An existing anti-stroke drug is an ... to suppress mucus overproduction, improve bacterial clearance and ... State University and the University of Rochester. , ... of Immunology, could result in a novel, non-antibiotic ... through topical drug delivery. Vinpocetine, the drug involved ...
Breaking Medicine News(10 mins):Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 3Health News:Local Lice Removal Company Partners with Schools to Combat Head Lice in the Classroom as Increase in Number of Cases Reported in May. 2Health News:Kim Barnas joins ThedaCare Center for Healthcare Value 2Health News:PharmApprove Panel at BIO Addresses Success in Drug Development Beyond Regulatory Approval 2Health News:PharmApprove Panel at BIO Addresses Success in Drug Development Beyond Regulatory Approval 3Health News:Anti-Stroke Drug Effective Treatment for Middle-Ear Infections, Researchers Say 2Health News:Anti-Stroke Drug Effective Treatment for Middle-Ear Infections, Researchers Say 3
... (Linkwell) (OTC Bulletin Board: LWLL), a leading developer,manufacturer ... today that it will file a Form 12b-25 ... 15-calendar day extension to file its 2007,Annual Report ... allow additional,time to complete the Company,s 2007 financial ...
... to 13 minutes, contrary to popular fantasy about the ... survey of U.S. and Canadian sex therapists., Penn State ... survey of 50 full members of the Society for ... workers, marriage/family therapists and nurses who have collectively seen ...
... CalbaTech,Inc. (OTC Bulletin Board: CLBE), the emerging life ... collection and banking of,adult stem cells for possible ... by $999,926 in 2007., CalbaTech announced revenues ... million in 2006. Gross profit in 2007 totaled ...
... Gan has established that patients with a high blood pressure ... capable of pumping blood against this pressure. Further, the right ... Gan is the first Mosaic laureate to gain his doctorate. ... out into the cause of high blood pressure in the ...
... University of Florida chemists are the first to use a ... -- without any previous knowledge of what these microscopic signatures ... the online edition of the Journal of Proteome Research, the ... treatment of some types of cancer as well as other ...
... Provides Interventional Cardiologists with Enhanced ... Faster, More Precise Procedures, CHICAGO, March 31 According ... 1 killer,with an average of one death every 37 seconds. ... contributed to the surge of,Americans with cardiac issues. To address ...
Cached Medicine News:Health News:Linkwell Corp to File to Extend Filing Date for 2007 Form 10-K 2Health News:Good sexual intercourse lasts minutes, not hours, therapists say 2Health News:CalbaTech Announces $999,926 Reduction in Debt; First Adult Stem Cell Harvesting Scheduled 2Health News:CalbaTech Announces $999,926 Reduction in Debt; First Adult Stem Cell Harvesting Scheduled 3Health News:Scientists: New technique identifies molecular 'biomarkers' for disease 2Health News:Scientists: New technique identifies molecular 'biomarkers' for disease 3Health News:See More, Do More: Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 2Health News:See More, Do More: Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 3Health News:See More, Do More: Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 4
Bipolar forceps...
... in vitro Nucleic Acid Hybridization ... Microplate Chemiluminescence for the Qualitative ... Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and 68 and ... High-Risk Groups in Cervical Specimens: ...
... superb radiation protection-0.62mm (+/- .05)Pb lead glass ... to their level of protection, they are ... smoothly on your bridge while hugging your ... wear corrective lenses, you can order Leaded ...
... first time in the world, there is a ... to diagnose VVC in female patients. CanDia5® is ... detect the Candida antigens almost instantaneously (within 5 ... blood. There is no similar POC product for ...
Medicine Products: